Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more

CytoDyn Inc. (OTCQX:CYDY) said Chairman Scott Kelly will also serve as CMO and head of business development. The company has treated 12 mild-to-moderate COVID-19 patients in

Read the full 266 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE